Developer docs
API playgroundTry for free, no card

Search company profiles

ABclonal

Full company profile

uuid0000slr

Namestring
ABclonal
Legal namestring
ABclonal, Inc.
Websiteurl
abclonal.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

ABclonal is a privately held life science reagents company founded in 2011 and headquartered in Wuhan, China, with US corporate operations (ABclonal, Inc.) based in Woburn, Massachusetts. The company develops and supplies research-grade antibodies, recombinant proteins, ELISA kits, molecular biology reagents, and next-generation sequencing solutions to academic and pharmaceutical researchers globally, organized around sub-brands including SMab (recombinant rabbit monoclonal antibodies), ABflo (flow cytometry), and PathoQ (IHC pathology). Its proprietary SMab™ platform integrates B cell sorting, enrichment, bioinformatics, and monoclonal antibody expression to produce recombinant rabbit monoclonal antibodies as the company's core technology differentiation, with a catalog spanning 4,000+ targets, 5,000+ SKUs, and 10,000+ antibody clones.

The company's business model is a hybrid of self-serve e-commerce through abclonal.com, direct phone/email sales for enterprise customers, and a global distributor network, with unit-based pay-as-you-go pricing and no publicly disclosed tiered subscription structure. Custom antibody, protein, and peptide synthesis services are offered through the toYurogen platform following the 2021 acquisition of Yurogen Biosystems. ABclonal monetizes primarily through one-time research reagent sales, targeting life science researchers (primary segment, including individual academic labs at institutions such as UCLA, Washington University in St. Louis, and McGill University) and pharmaceutical/biotech companies (secondary segment, for drug discovery and target validation). Two large funding rounds in 2021 totaling approximately $282 million (Series B: $93M; Series C: $189M) and recognition in CiteAb's 2024 Top 100 Most Cited RUO Antibodies dataset indicate the company has achieved meaningful scale relative to peers but remains an emerging challenger to established incumbents Cell Signaling Technology, Abcam, and Thermo Fisher Scientific.

Short descriptiontext

ABclonal is a China-founded, privately held life science reagents company that develops and supplies research antibodies, recombinant proteins, ELISA kits, and molecular biology reagents to academic and pharmaceutical researchers worldwide via direct e-commerce, distributor networks, and US operations in Woburn, MA.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWoburn, United States
HQ citystring
Woburn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
research antibodies, recombinant proteins, molecular biology reagents, ELISA kits, flow cytometry reagents
Industry3 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Life Science Research Reagents
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research reagent product sales
TypeOne Time License
Description

ABclonal generates revenue through the sale of research reagents including antibodies (primary, secondary, flow cytometry, IHC), proteins, ELISA kits, molecular biology reagents (PCR, qPCR, cloning, electrophoresis), next-generation sequencing reagents, and recombinant proteins to life science researchers in academia and pharma.

abclonal.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Catalog products available for individual purchase
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products ordered individually through catalog; no tiered pricing structure publicly visible

abclonal.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1SMab
Description

A new generation of recombinant rabbit monoclonal antibodies generated with SMab technology that integrates B cell sorting, enrichment, bioinformatics, and monoclonal antibody expression.

abclonal.com
+2 more records
Core offering1 text field

ABclonal develops, manufactures, and sells research-use antibodies and molecular reagents to life science laboratories. Its core catalog spans primary and secondary antibodies, recombinant rabbit monoclonal antibodies made with proprietary SMab™ technology, flow cytometry antibodies (ABflo), IHC pathology antibodies (PathoQ), molecular biology reagents (PCR, qPCR, cloning, electrophoresis), next-generation sequencing library prep reagents, recombinant proteins, and ELISA kits. Products are sold globally to academic researchers, pharmaceutical companies, and biotech firms.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ABclonal is a life science reagents company offering a comprehensive portfolio of research antibodies, proteins, molecular biology reagents, next-generation sequencing solutions, and ELISA kits. The core products include SMab recombinant monoclonal antibodies (a proprietary technology integrating B cell sorting, bioinformatics, and antibody expression), primary antibodies (polyclonal, monoclonal, and recombinant), secondary antibodies, and specialized antibodies for flow cytometry (ABflo), immunohistochemistry (PathoQ), and post-translational modifications. The molecular biology reagent portfolio spans PCR, reverse transcription, qPCR, cloning, and nucleic acid electrophoresis. NGS solutions cover library preparation for DNA, RNA, and single cells, plus epigenetic analysis. Recombinant proteins include cell culture reagents, CAR-T/NK proteins, viral antigens, and kinases. Services include custom antibody, protein, and peptide development through the toYurogen platform.

Product and service14 records
1SMab Recombinant Monoclonal Antibodies
CategoryPrimary Antibodies
Description

Next-generation recombinant rabbit monoclonal antibodies generated using SMab™ technology that integrates B cell sorting, enrichment, bioinformatics, and monoclonal antibody expression for high-specificity research applications.

2Primary Antibodies (Polyclonal and Monoclonal)
CategoryPrimary Antibodies
Description

Catalog of polyclonal and monoclonal antibodies covering 4,000+ targets with 5,000+ catalog items and 10,000+ antibody clones for research use across multiple applications.

3Secondary Antibodies
CategorySecondary Antibodies
Description

Secondary antibodies used in immunoassays and detection methods to amplify signal in antibody-based experiments.

4ABflo Flow Cytometry Antibodies
CategoryFlow Cytometry Reagents
Description

Flow cytometry antibodies for immunophenotyping and cell analysis applications, including anti-monkey variants and flow cytometry panels.

5PathoQ IHC Pathology Antibodies
CategoryImmunohistochemistry Antibodies
Description

Immunohistochemistry-validated antibodies for pathological tissue analysis and diagnostic research applications.

6KO/KD Validated Antibodies
CategoryPrimary Antibodies
Description

Knockout/knockdown validated antibodies providing orthogonal specificity validation to support reproducible research results.

7PTM-specific Antibodies
CategoryPrimary Antibodies
Description

Post-translational modification-specific antibodies including phospho-specific, methyl-specific, acetyl-specific, and other PTM-targeting variants.

8Molecular Biology Reagents
CategoryMolecular Biology Reagents
Description

Reagents for PCR (conventional, fast, isothermal, high-fidelity, direct), reverse transcription kits, qPCR reagents (dye-based, probe-based, one-step RT-qPCR, SNP genotyping), cloning tools, restriction endonucleases, ligases, and nucleic acid electrophoresis products.

9Next-Generation Sequencing (NGS) Solutions
CategoryNGS Library Prep
Description

NGS library preparation reagents including DNA and RNA library prep, single-cell library preparation, epigenetic analysis tools, hybridization capture reagents, and raw material enzymes.

10Recombinant Proteins
CategoryRecombinant Proteins
Description

Cell culture proteins for macrophage/osteoclast, dendritic cell, T/B/NK cell, stem cell, and organoid culture; CAR-T and CAR-NK proteins; CD antigens; biomarker proteins; Fc/Fc receptor proteins; viral antigens (SARS-CoV-2, influenza, monkeypox, coronavirus); and enzymes including kinases.

11ELISA Kits
CategoryELISA Kits
Description

Enzyme-linked immunosorbent assay kits available in economical, high-sensitivity, fast-detection, and high-performance formats, including matched antibody pairs for analyte quantification.

12Multiplex Assay Kits
CategoryELISA Kits
Description

Multiplex assay kits enabling simultaneous detection of multiple analytes within a single sample.

13Custom Antibody and Protein Services (toYurogen)
CategoryCustom Services
Description

Custom antibody and protein development services offered through the toYurogen platform acquired in 2021.

14Custom Peptide Synthesis Services (toYurogen)
CategoryCustom Services
Description

Custom peptide synthesis services offered through the toYurogen platform.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for antibody characterization and standardization efforts

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration supporting Parkinson's disease research through antibody development

3mAb3D Atlas
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for 3D antibody atlas characterization

abclonal.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based leading supplier of research antibodies with a deep catalog across key signaling pathways and applications including WB, IHC, IP, and flow cytometry. Directly comparable to ABclonal as a primary antibody-focused reagent supplier serving academic and pharma researchers.

TypeDirect peer
Description

Global research antibody reagent supplier (now part of Danaher) with one of the broadest catalogs in the industry, cited extensively in publications. Directly comparable to ABclonal in target coverage, validation approach, and customer base.

TypeDirect peer
Description

Research antibody supplier with a large catalog and a reputation for KO/KD-validated antibodies. Closely comparable to ABclonal in its China-origin emergence story, recombinant antibody offering, and academic customer base.

4Santa Cruz Biotechnology
TypeDirect peer
Description

Long-established research antibody supplier offering polyclonal, monoclonal, and secondary antibodies across a wide target range. Comparable to ABclonal in catalog breadth and academic customer focus, though with a more US-centric footprint.

TypeDirect peer
Description

Major supplier of antibodies and reagents for flow cytometry, immunology, and cell biology research, now part of Revvity. Comparable to ABclonal's ABflo flow cytometry product line and broader immunology/cell biology focus.

TypeBroad incumbent
Description

Diversified life science tools company encompassing R&D Systems, Novus Biologicals, ProteinSimple, and other reagent/antibody brands. Comparable to ABclonal in research antibody and protein reagent offerings, with a much broader portfolio across proteins, antibodies, and instruments.

TypeDirect peer
Description

Global biotech with research reagent, custom antibody service, and gene synthesis businesses, including the GenScript Antibody platform. Comparable to ABclonal in custom antibody services, recombinant protein catalog, and China-to-global commercial trajectory.

TypeBroad incumbent
Description

Largest life science tools conglomerate with antibodies sold under Invitrogen, Thermo Scientific, and Pierce brands. Comparable to ABclonal in catalog breadth and customer base, but operates as a broad incumbent across instruments, consumables, and reagents rather than a focused antibody specialist.

TypeDirect peer
Description

Sweden-based supplier of precision antibodies with a focus on tissue-specific targets and IHC-validated reagents. Comparable to ABclonal's PathoQ IHC pathology line and emphasis on application-specific validation.

TypeEmerging player
Description

China-based research antibody supplier with growing global presence and a similar China-origin, catalog-focused GTM motion. Most directly comparable to ABclonal as a near-peer emerging competitor from the same Chinese ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ABclonal

Life Science Research Reagentsabclonal.com

ABclonal is a China-founded, privately held life science reagents company that develops and supplies research antibodies, recombinant proteins, ELISA kits, and molecular biology reagents to academic and pharmaceutical researchers worldwide via direct e-commerce, distributor networks, and US operations in Woburn, MA.

What ABclonal does

ABclonal is a privately held life science reagents company founded in 2011 and headquartered in Wuhan, China, with US corporate operations (ABclonal, Inc.) based in Woburn, Massachusetts. The company develops and supplies research-grade antibodies, recombinant proteins, ELISA kits, molecular biology reagents, and next-generation sequencing solutions to academic and pharmaceutical researchers globally, organized around sub-brands including SMab (recombinant rabbit monoclonal antibodies), ABflo (flow cytometry), and PathoQ (IHC pathology). Its proprietary SMab™ platform integrates B cell sorting, enrichment, bioinformatics, and monoclonal antibody expression to produce recombinant rabbit monoclonal antibodies as the company's core technology differentiation, with a catalog spanning 4,000+ targets, 5,000+ SKUs, and 10,000+ antibody clones.

The company's business model is a hybrid of self-serve e-commerce through abclonal.com, direct phone/email sales for enterprise customers, and a global distributor network, with unit-based pay-as-you-go pricing and no publicly disclosed tiered subscription structure. Custom antibody, protein, and peptide synthesis services are offered through the toYurogen platform following the 2021 acquisition of Yurogen Biosystems. ABclonal monetizes primarily through one-time research reagent sales, targeting life science researchers (primary segment, including individual academic labs at institutions such as UCLA, Washington University in St. Louis, and McGill University) and pharmaceutical/biotech companies (secondary segment, for drug discovery and target validation). Two large funding rounds in 2021 totaling approximately $282 million (Series B: $93M; Series C: $189M) and recognition in CiteAb's 2024 Top 100 Most Cited RUO Antibodies dataset indicate the company has achieved meaningful scale relative to peers but remains an emerging challenger to established incumbents Cell Signaling Technology, Abcam, and Thermo Fisher Scientific.

ABclonal firmographics

Firmographics
Name
ABclonal
Legal name
ABclonal, Inc.
Website
https://abclonal.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
51–100 employees
Short description
ABclonal is a China-founded, privately held life science reagents company that develops and supplies research antibodies, recombinant proteins, ELISA kits, and molecular biology reagents to academic and pharmaceutical researchers worldwide via direct e-commerce, distributor networks, and US operations in Woburn, MA.
Ownership category
akta.pro rank

ABclonal industry classification

Industry
Product category
Life Science Research Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Research antibodies
  • Recombinant proteins
  • Molecular biology reagents
  • ELISA kits
  • Flow cytometry reagents

Where ABclonal is headquartered

Location

Headquarters

HQ city
Woburn
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ABclonal business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Research reagent product sales: ABclonal generates revenue through the sale of research reagents including antibodies (primary, secondary, flow cytometry, IHC), proteins, ELISA kits, molecular biology reagents (PCR, qPCR, cloning, electrophoresis), next-generation sequencing reagents, and recombinant proteins to life science researchers in academia and pharma.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCatalog products available for individual purchase

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

ABclonal product offering

Product offering

Core offering

ABclonal develops, manufactures, and sells research-use antibodies and molecular reagents to life science laboratories. Its core catalog spans primary and secondary antibodies, recombinant rabbit monoclonal antibodies made with proprietary SMab™ technology, flow cytometry antibodies (ABflo), IHC pathology antibodies (PathoQ), molecular biology reagents (PCR, qPCR, cloning, electrophoresis), next-generation sequencing library prep reagents, recombinant proteins, and ELISA kits. Products are sold globally to academic researchers, pharmaceutical companies, and biotech firms.

Product overview

ABclonal is a life science reagents company offering a comprehensive portfolio of research antibodies, proteins, molecular biology reagents, next-generation sequencing solutions, and ELISA kits. The core products include SMab recombinant monoclonal antibodies (a proprietary technology integrating B cell sorting, bioinformatics, and antibody expression), primary antibodies (polyclonal, monoclonal, and recombinant), secondary antibodies, and specialized antibodies for flow cytometry (ABflo), immunohistochemistry (PathoQ), and post-translational modifications. The molecular biology reagent portfolio spans PCR, reverse transcription, qPCR, cloning, and nucleic acid electrophoresis. NGS solutions cover library preparation for DNA, RNA, and single cells, plus epigenetic analysis. Recombinant proteins include cell culture reagents, CAR-T/NK proteins, viral antigens, and kinases. Services include custom antibody, protein, and peptide development through the toYurogen platform.

Differentiator

Problem solved

Functional benefit

Brands

  • SMab: A new generation of recombinant rabbit monoclonal antibodies generated with SMab technology that integrates B cell sorting, enrichment, bioinformatics, and monoclonal antibody expression.
  • ABflo
  • PathoQ

Products and services

  • SMab Recombinant Monoclonal Antibodies Next-generation recombinant rabbit monoclonal antibodies generated using SMab™ technology that integrates B cell sorting, enrichment, bioinformatics, and monoclonal antibody expression for high-specificity research applications.
  • Primary Antibodies (Polyclonal and Monoclonal) Catalog of polyclonal and monoclonal antibodies covering 4,000+ targets with 5,000+ catalog items and 10,000+ antibody clones for research use across multiple applications.
  • Secondary Antibodies Secondary antibodies used in immunoassays and detection methods to amplify signal in antibody-based experiments.
  • ABflo Flow Cytometry Antibodies Flow cytometry antibodies for immunophenotyping and cell analysis applications, including anti-monkey variants and flow cytometry panels.
  • PathoQ IHC Pathology Antibodies Immunohistochemistry-validated antibodies for pathological tissue analysis and diagnostic research applications.
  • KO/KD Validated Antibodies Knockout/knockdown validated antibodies providing orthogonal specificity validation to support reproducible research results.
  • PTM-specific Antibodies Post-translational modification-specific antibodies including phospho-specific, methyl-specific, acetyl-specific, and other PTM-targeting variants.
  • Molecular Biology Reagents Reagents for PCR (conventional, fast, isothermal, high-fidelity, direct), reverse transcription kits, qPCR reagents (dye-based, probe-based, one-step RT-qPCR, SNP genotyping), cloning tools, restriction endonucleases, ligases, and nucleic acid electrophoresis products.
  • Next-Generation Sequencing (NGS) Solutions NGS library preparation reagents including DNA and RNA library prep, single-cell library preparation, epigenetic analysis tools, hybridization capture reagents, and raw material enzymes.
  • Recombinant Proteins Cell culture proteins for macrophage/osteoclast, dendritic cell, T/B/NK cell, stem cell, and organoid culture; CAR-T and CAR-NK proteins; CD antigens; biomarker proteins; Fc/Fc receptor proteins; viral antigens (SARS-CoV-2, influenza, monkeypox, coronavirus); and enzymes including kinases.
  • ELISA Kits Enzyme-linked immunosorbent assay kits available in economical, high-sensitivity, fast-detection, and high-performance formats, including matched antibody pairs for analyte quantification.
  • Multiplex Assay Kits Multiplex assay kits enabling simultaneous detection of multiple analytes within a single sample.
  • Custom Antibody and Protein Services (toYurogen) Custom antibody and protein development services offered through the toYurogen platform acquired in 2021.
  • Custom Peptide Synthesis Services (toYurogen) Custom peptide synthesis services offered through the toYurogen platform.

Companies that use ABclonal

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

ABclonal technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

ABclonal partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

  • YCharOSminorStrategic or Co-development PartnerPartnership for antibody characterization and standardization efforts
  • Michael J. Fox Foundation (MJFF)minorStrategic or Co-development PartnerCollaboration supporting Parkinson's disease research through antibody development
  • mAb3D AtlasminorStrategic or Co-development PartnerPartnership for 3D antibody atlas characterization

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

ABclonal competitors and assessment

Company assessment

Direct peers

  • Cell Signaling Technology: US-based leading supplier of research antibodies with a deep catalog across key signaling pathways and applications including WB, IHC, IP, and flow cytometry. Directly comparable to ABclonal as a primary antibody-focused reagent supplier serving academic and pharma researchers.
  • Abcam: Global research antibody reagent supplier (now part of Danaher) with one of the broadest catalogs in the industry, cited extensively in publications. Directly comparable to ABclonal in target coverage, validation approach, and customer base.
  • Proteintech: Research antibody supplier with a large catalog and a reputation for KO/KD-validated antibodies. Closely comparable to ABclonal in its China-origin emergence story, recombinant antibody offering, and academic customer base.
  • Santa Cruz Biotechnology: Long-established research antibody supplier offering polyclonal, monoclonal, and secondary antibodies across a wide target range. Comparable to ABclonal in catalog breadth and academic customer focus, though with a more US-centric footprint.
  • BioLegend (Revvity): Major supplier of antibodies and reagents for flow cytometry, immunology, and cell biology research, now part of Revvity. Comparable to ABclonal's ABflo flow cytometry product line and broader immunology/cell biology focus.
  • GenScript: Global biotech with research reagent, custom antibody service, and gene synthesis businesses, including the GenScript Antibody platform. Comparable to ABclonal in custom antibody services, recombinant protein catalog, and China-to-global commercial trajectory.
  • Atlas Antibodies: Sweden-based supplier of precision antibodies with a focus on tissue-specific targets and IHC-validated reagents. Comparable to ABclonal's PathoQ IHC pathology line and emphasis on application-specific validation.

Broad incumbents

  • Bio-Techne: Diversified life science tools company encompassing R&D Systems, Novus Biologicals, ProteinSimple, and other reagent/antibody brands. Comparable to ABclonal in research antibody and protein reagent offerings, with a much broader portfolio across proteins, antibodies, and instruments.
  • Thermo Fisher Scientific: Largest life science tools conglomerate with antibodies sold under Invitrogen, Thermo Scientific, and Pierce brands. Comparable to ABclonal in catalog breadth and customer base, but operates as a broad incumbent across instruments, consumables, and reagents rather than a focused antibody specialist.

Emerging players

  • HuaBio (Hangzhou HuaAn Biotechnology): China-based research antibody supplier with growing global presence and a similar China-origin, catalog-focused GTM motion. Most directly comparable to ABclonal as a near-peer emerging competitor from the same Chinese ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ABclonal social profiles

Digital presence

ABclonal financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ABclonal leadership team

Management profile

Number of profiles

Profiles1 record

ABclonal funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ABclonal M&A and investment

M&A and investment

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ABclonal

What does ABclonal do?

ABclonal develops, manufactures, and sells research-use antibodies and molecular reagents to life science laboratories. Its core catalog spans primary and secondary antibodies, recombinant rabbit monoclonal antibodies made with proprietary SMab™ technology, flow cytometry antibodies (ABflo), IHC pathology antibodies (PathoQ), molecular biology reagents (PCR, qPCR, cloning, electrophoresis), next-generation sequencing library prep reagents, recombinant proteins, and ELISA kits. Products are sold globally to academic researchers, pharmaceutical companies, and biotech firms.

Is ABclonal a public or private company?

ABclonal is a private company. It is classified as venture growth investor backed and is currently operating.

When was ABclonal founded?

ABclonal was founded in 2011. It employs 51 to 100 people.

Where is ABclonal based?

ABclonal is headquartered in Woburn, United States, in the North America region.

How does ABclonal make money?

One revenue line is on record: research reagent product sales.

Who are ABclonal's main competitors?

Direct peers on record are Cell Signaling Technology, Abcam, Proteintech, Santa Cruz Biotechnology, BioLegend (Revvity), GenScript and Atlas Antibodies. Broad incumbents are Bio-Techne and Thermo Fisher Scientific. HuaBio (Hangzhou HuaAn Biotechnology) is listed as an emerging player.

Does ABclonal have an API?

No public API is recorded for ABclonal.

What industry is ABclonal in?

ABclonal's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire APACABclonal Technology Joins YCharOS Industry Advisory Committee to Tackle Reproducibility Crisis in Biomedical ResearchABclonal Technology joined YCharOS's Industry Advisory Committee to address the reproducibility crisis in biomedical research. The company will provide antibodies for YCharOS's head-to-head comparisons of commercially available antibodies. ABclonal's CEO cited the need for specificity to yield reproducible results.PR NewswireABclonal Technology Joins YCharOS Industry Advisory Committee to Tackle Reproducibility Crisis in Biomedical ResearchABclonal Technology announced it has joined the Industry Advisory Committee (IAC) at YCharOS Inc., an open science company focused on characterizing commercially available antibody reagents for all human proteins. The partnership aims to address the reproducibility crisis in biomedical research by having ABclonal contribute antibodies for head-to-head validation comparisons that YCharOS publishes transparently. ABclonal CEO Zack Wu stated the company was founded on the vision of producing high-quality antibodies for every human protein, with reproducibility as a core focus.PR NewswireABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers WorldwideABclonal Biotechnology Co., Ltd. has acquired Yurogen Biosystems LLC, a contract research organization specializing in monoclonal antibody discovery using its proprietary single-B-cell-based SMab platform. The acquisition, following ABclonal's $93 million Series C funding, enables ABclonal to expand from academic research reagents into the in vitro diagnostic and antibody drug discovery markets, adding recombinant rabbit monoclonal antibody production capabilities. ABclonal plans to invest $30 million over three years to launch more than 10,000 new recombinant rabbit monoclonal antibody products for global diagnostic and pharmaceutical research markets.PR Newswire APACABclonal Biotechnology Completes $93 Million Series C FinancingABclonal Biotechnology completed a $92.9 million Series C financing led by Sequoia Capital China and LYFE Capital. The company will use the funds to accelerate R&D for in vitro diagnostic raw materials and expand production of research reagents. It is also in talks to acquire a contract research organization for single-cell antibody development.PR NewswireABclonal Biotechnology Completes $93 Million Series C FinancingABclonal Biotechnology completed a $92.9 million Series C financing round led by Sequoia Capital China and LYFE Capital, with participation from Sigma Square Capital, Kinghall Ventures, and Lucion Capital. The funding will accelerate R&D for in vitro diagnostic raw materials and expand production capabilities for research reagent products and services. The company is also in talks to acquire a contract research organization focused on single-cell-based monoclonal antibody development as its first step toward global expansion.GlobeNewswireABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel ProductsABclonal Technology partnered with BenchSci to use machine learning to improve discoverability of its antibody products on search engines. The collaboration aims to help scientists find ABclonal's reagents regardless of citation counts, and scientists have already started purchasing on the BenchSci marketplace.GlobeNewswireABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel ProductsABclonal Technology partnered with BenchSci to improve discoverability of its antibody products on search engines. BenchSci's AI platform will identify published data and display validation figures, helping scientists find antibodies regardless of citation count. The collaboration aims to boost ABclonal's brand value and challenge established vendors.GlobeNewswireABclonal Technology Unveils Next-Generation Sequencing Kits for Illumina Sequencing PlatformsABclonal Technology unveiled next-generation sequencing library preparation kits for Illumina platforms, including DNA and RNA kits. The kits achieve up to 70% DNA conversion efficiency with 500 picograms of input, with DNA kits starting at $218 and RNA kits at $558.